These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 32115705)

  • 21. Na+-dependent SR Ca2+ overload induces arrhythmogenic events in mouse cardiomyocytes with a human CPVT mutation.
    Sedej S; Heinzel FR; Walther S; Dybkova N; Wakula P; Groborz J; Gronau P; Maier LS; Vos MA; Lai FA; Napolitano C; Priori SG; Kockskämper J; Pieske B
    Cardiovasc Res; 2010 Jul; 87(1):50-9. PubMed ID: 20080988
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Catecholaminergic polymorphic ventricular tachycardia from bedside to bench and beyond.
    Katz G; Arad M; Eldar M
    Curr Probl Cardiol; 2009 Jan; 34(1):9-43. PubMed ID: 19068246
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Novel Calmodulin Variant p.E46K Associated With Severe Catecholaminergic Polymorphic Ventricular Tachycardia Produces Robust Arrhythmogenicity in Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes.
    Gao J; Makiyama T; Yamamoto Y; Kobayashi T; Aoki H; Maurissen TL; Wuriyanghai Y; Kashiwa A; Imamura T; Aizawa T; Huang H; Kohjitani H; Nishikawa M; Chonabayashi K; Fukuyama M; Manabe H; Nakau K; Wada T; Kato K; Toyoda F; Yoshida Y; Makita N; Woltjen K; Ohno S; Kurebayashi N; Murayama T; Sakurai T; Horie M; Kimura T
    Circ Arrhythm Electrophysiol; 2023 Mar; 16(3):e011387. PubMed ID: 36866681
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inherited dysfunction of sarcoplasmic reticulum Ca2+ handling and arrhythmogenesis.
    Priori SG; Chen SR
    Circ Res; 2011 Apr; 108(7):871-83. PubMed ID: 21454795
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Arrhythmogenesis in a catecholaminergic polymorphic ventricular tachycardia mutation that depresses ryanodine receptor function.
    Zhao YT; Valdivia CR; Gurrola GB; Powers PP; Willis BC; Moss RL; Jalife J; Valdivia HH
    Proc Natl Acad Sci U S A; 2015 Mar; 112(13):E1669-77. PubMed ID: 25775566
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical and molecular characterization of patients with catecholaminergic polymorphic ventricular tachycardia.
    Priori SG; Napolitano C; Memmi M; Colombi B; Drago F; Gasparini M; DeSimone L; Coltorti F; Bloise R; Keegan R; Cruz Filho FE; Vignati G; Benatar A; DeLogu A
    Circulation; 2002 Jul; 106(1):69-74. PubMed ID: 12093772
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Modulation of SR Ca release by luminal Ca and calsequestrin in cardiac myocytes: effects of CASQ2 mutations linked to sudden cardiac death.
    Terentyev D; Kubalova Z; Valle G; Nori A; Vedamoorthyrao S; Terentyeva R; Viatchenko-Karpinski S; Bers DM; Williams SC; Volpe P; Gyorke S
    Biophys J; 2008 Aug; 95(4):2037-48. PubMed ID: 18469084
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Catecholaminergic polymorphic ventricular tachycardia.
    Liu N; Ruan Y; Priori SG
    Prog Cardiovasc Dis; 2008; 51(1):23-30. PubMed ID: 18634915
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ryanodine receptor-mediated arrhythmias and sudden cardiac death.
    Blayney LM; Lai FA
    Pharmacol Ther; 2009 Aug; 123(2):151-77. PubMed ID: 19345240
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Description of a novel RyR2 mutation in a juvenile patient with symptomatic catecholaminergic polymorphic ventricular tachycardia in sleep and during exercise: a case report.
    Seidlmayer LK; Riediger F; Pagonas N; Nordbeck P; Ritter O; Sasko B
    J Med Case Rep; 2018 Oct; 12(1):298. PubMed ID: 30296944
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Disruption of calcium homeostasis and arrhythmogenesis induced by mutations in the cardiac ryanodine receptor and calsequestrin.
    Liu N; Priori SG
    Cardiovasc Res; 2008 Jan; 77(2):293-301. PubMed ID: 18006488
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Divergent regulation of ryanodine receptor 2 calcium release channels by arrhythmogenic human calmodulin missense mutants.
    Hwang HS; Nitu FR; Yang Y; Walweel K; Pereira L; Johnson CN; Faggioni M; Chazin WJ; Laver D; George AL; Cornea RL; Bers DM; Knollmann BC
    Circ Res; 2014 Mar; 114(7):1114-24. PubMed ID: 24563457
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genetic background of catecholaminergic polymorphic ventricular tachycardia in Japan.
    Kawamura M; Ohno S; Naiki N; Nagaoka I; Dochi K; Wang Q; Hasegawa K; Kimura H; Miyamoto A; Mizusawa Y; Itoh H; Makiyama T; Sumitomo N; Ushinohama H; Oyama K; Murakoshi N; Aonuma K; Horigome H; Honda T; Yoshinaga M; Ito M; Horie M
    Circ J; 2013; 77(7):1705-13. PubMed ID: 23595086
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Absence of triadin, a protein of the calcium release complex, is responsible for cardiac arrhythmia with sudden death in human.
    Roux-Buisson N; Cacheux M; Fourest-Lieuvin A; Fauconnier J; Brocard J; Denjoy I; Durand P; Guicheney P; Kyndt F; Leenhardt A; Le Marec H; Lucet V; Mabo P; Probst V; Monnier N; Ray PF; Santoni E; Trémeaux P; Lacampagne A; Fauré J; Lunardi J; Marty I
    Hum Mol Genet; 2012 Jun; 21(12):2759-67. PubMed ID: 22422768
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dantrolene rescues arrhythmogenic RYR2 defect in a patient-specific stem cell model of catecholaminergic polymorphic ventricular tachycardia.
    Jung CB; Moretti A; Mederos y Schnitzler M; Iop L; Storch U; Bellin M; Dorn T; Ruppenthal S; Pfeiffer S; Goedel A; Dirschinger RJ; Seyfarth M; Lam JT; Sinnecker D; Gudermann T; Lipp P; Laugwitz KL
    EMBO Mol Med; 2012 Mar; 4(3):180-91. PubMed ID: 22174035
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sarcoplasmic Reticulum Ca
    Du Y; Demillard LJ; Ren J
    Biochem Pharmacol; 2022 Jun; 200():115059. PubMed ID: 35490731
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neuronal Na+ channel blockade suppresses arrhythmogenic diastolic Ca2+ release.
    Radwański PB; Brunello L; Veeraraghavan R; Ho HT; Lou Q; Makara MA; Belevych AE; Anghelescu M; Priori SG; Volpe P; Hund TJ; Janssen PM; Mohler PJ; Bridge JH; Poelzing S; Györke S
    Cardiovasc Res; 2015 Apr; 106(1):143-52. PubMed ID: 25538156
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cell model of catecholaminergic polymorphic ventricular tachycardia reveals early and delayed afterdepolarizations.
    Kujala K; Paavola J; Lahti A; Larsson K; Pekkanen-Mattila M; Viitasalo M; Lahtinen AM; Toivonen L; Kontula K; Swan H; Laine M; Silvennoinen O; Aalto-Setälä K
    PLoS One; 2012; 7(9):e44660. PubMed ID: 22962621
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The clinical and genetic spectrum of catecholaminergic polymorphic ventricular tachycardia: findings from an international multicentre registry.
    Roston TM; Yuchi Z; Kannankeril PJ; Hathaway J; Vinocur JM; Etheridge SP; Potts JE; Maginot KR; Salerno JC; Cohen MI; Hamilton RM; Pflaumer A; Mohammed S; Kimlicka L; Kanter RJ; LaPage MJ; Collins KK; Gebauer RA; Temple JD; Batra AS; Erickson C; Miszczak-Knecht M; Kubuš P; Bar-Cohen Y; Kantoch M; Thomas VC; Hessling G; Anderson C; Young ML; Choi SHJ; Cabrera Ortega M; Lau YR; Johnsrude CL; Fournier A; Van Petegem F; Sanatani S
    Europace; 2018 Mar; 20(3):541-547. PubMed ID: 28158428
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Calsequestrin 2 and arrhythmias.
    Faggioni M; Knollmann BC
    Am J Physiol Heart Circ Physiol; 2012 Mar; 302(6):H1250-60. PubMed ID: 22198169
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.